赛诺巴酸在与瘤相关的发症中的有效性
Guido Chiriboga1, Adrian Safa2, Anteneh Feyissa2
1Mayo Clinic Alix School of Medicine, Jacksonville, Florida, USA.
塞诺巴马特在治疗瘤相关发症 (TRE) 中表现有前途,在一小群患者中显著降低了发作频率. 耐药性并不能预测疗效,在接受化疗的患者中也没有发现任何不良事件.
科学领域:
- 神经学 神经学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 与瘤相关的 (TRE) 在管理方面提出了独特的挑战.
- 塞诺巴马特是一种经批准的抗发作药物,具有潜在的抗瘤作用.
- 有限的数据存在于TRE患者中塞诺巴马特的疗效和安全性.
研究的目的:
- 评估赛诺巴酸盐作为瘤相关发症 (TRE) 辅助治疗的疗效和安全性.
- 确定预测TRE.患者对塞诺巴酸的反应的因素.
主要方法:
- 对17名TRE患者进行了回顾性多中心研究,这些患者接受了Cenobamate治疗.
- 从2020年1月到2024年11月在梅奥诊所地点收集的数据.
- 通过减少发作频率来评估有效性;分析预测因素.
主要成果:
- 每月发作频率中位数 (56.3%) 显著减少,从12个减少到3个.
- 23.5%的患者实现了无发作;41.1%的患者有反应 (≥50%的减少).
- 在接受并发化疗的患者中没有报告任何不良事件;没有临床因素预测反应.
结论:
- 辅助赛诺巴酸治疗是TRE的可行和潜在的有效选择.
- 临床病史,包括药物耐药性,并不能预测治疗疗效.
- 需要进行进一步的研究来证实青酸盐在TRE中的疗效和安全性.
更多相关视频
09:46Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus
Published on: March 8, 2015
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Electroconvulsive Therapy
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
